SOPHiA GENETICS (NasdaqGS:SOPH) remains unprofitable, with losses widening at an annual rate of 4% over the past five years. The company’s revenue is projected to climb 17.91% per year, outpacing the ...
Fintel reports that on November 4, 2025, TD Cowen maintained coverage of Myriad Genetics (NasdaqGS:MYGN) with a Hold ...
Fintel reports that on October 29, 2025, Wedbush initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Outperform ...
Check the CBSE Class 11 Biotechnology Deleted Syllabus 2025–26 to know the removed topics from key units and practicals.
As shifting rain patterns and rising heat challenge farmers, Cornell’s Prof. Margaret Smith underscores that sustaining ...
Jurassic World Evolution 3 is the latest entry in Frontier's series of builders where the player creates a dinosaur-themed ...
At Rutgers NJMS, art and music are helping future doctors strengthen empathy, sharpen observation skills and bring humanity ...
Illumina (ILMN) is capturing attention following the debut of its proprietary 5-base sequencing solution and impressive results from GeneDx’s pilot of the constellation platform. Both developments ...
Q3 2025 Earnings Call November 5, 2025 2:00 AM ESTCompany ParticipantsIvan Vindheim - Chief Executive OfficerKristian Ellingsen ...
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both ... and a variety of other fundamentals that help us determine a company's fair value. KMDA ...
Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...
12d
The Experts Have Spoken: These Are the 13 Best Supplements for Winter to Keep Your Health in Check
"Vitamin D is absolutely vital in winter, when we don’t get enough sunlight to make it ourselves, supporting immune and bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback